In-vitro fertilization (IVF) Industry By Types of cycle (Fresh Cycle (Non-Donor), Thawed IVF Cycle (Non-Donor), Donor Egg IVF Cycle) By Application (Fertility Clinics, Hospitals, Surgical Centers) - Global Size Analysis and Market Forecast 2019-2025
Report ID: 10078312 |
Published Date: 21 Oct 2022 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
Global In-vitro fertilization (IVF) Industry was valued at USD 508 Million in the year 2017. Global In-vitro fertilization (IVF) Industry is further estimated to grow at a CAGR of 10.4 % from 2019 to reach USD 1121.51 Million by the year 2025. North America region holds the highest Industry share in 2017 and Europe is considered as the fastest growing Industry in the forecasted period. At country level, developed industries U.S holds a substantial Industry share in 2017 and it is projected to grow at a gradual pace in the coming years.
Major market players in In-Vitro Fertilization (IVF) Industry are OvaScience, EMD Serono Inc., Irvine Scientific, CooperSurgical Inc., Vitrolife AB, Cook Medical Inc., Progyny Inc., Genea Biomedx, Boston IVF, Kitazato Corp, and other brief information of 10 companies will be provided in report. Rising research and development expenses to address the changing demand of end users, similarly growth strategies such as acquisition, merger and expansion of the distribution network were few techniques adopted by most of the top players in the last 5 years.
SWOT Analysis of IN-Vitro Fertilization (IVF) Industry:
Strength:
Declining fertility rate
Increasing incidences of male and female infertility
Weakness:
High Cost and Low Success Rate of the IVF Treatment
Lack of regulatory framework
Opportunities:
Availability of supportive government funding
Fertility Tourism
Threats:
Reducing Efficacy of Infertility Treatment with Advancing Age
Ethical considerations
The global in-vitro fertilization (IVF) Industry id segmented on the basis of types of cycle, by application and by region. On the basis of types of cycle the Industry is segmented as Fresh Cycle (Non-Donor), Thawed IVF Cycle (Non-Donor) and Donor Egg IVF Cycle of which Fresh Cycle (Non-Donor) segment is expected to hold the highest Industry share during the forecast period.
On the basis of application the Industry is segmented as Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes, in which Fertility Clinics holds the highest Industry share.
In-Vitro Fertilization (IVF) Industry:
By Types of cycle
• Fresh Cycle (Non-Donor)
• Thawed IVF Cycle (Non-Donor)
• Donor Egg IVF Cycle
By Application
• Fertility Clinics
• Hospitals
• Surgical Centers
• Clinical Research Institutes
By Region
• North America
o USA
o Canada
• Europe
o Germany
o U.K.
o France
o Italy
o Rest of Europe
• APAC
o China
o India
o Japan
o Rest of Asia-Pacific
• RoW
o Latin America
o Middle East & Africa
ㄮ
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
Report ID: 10078312 |
Published Date: 21 Oct 2022 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
More Reports from Healthcare & Pharmaceuticals Sector
Thank you for contacting us!
""We have received your sample request for the research report. Our research representative will contact you shortly.""
Get a free sample of this report
In-vitro fertilization (IVF) Market
JUMP TO CONTENT